Matches in Wikidata for { <http://www.wikidata.org/entity/Q91037232> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91037232 description "2019 թվականի հունվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q91037232 description "article scientifique publié en 2019" @default.
- Q91037232 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91037232 description "scientific article published on 11 January 2019" @default.
- Q91037232 description "wetenschappelijk artikel" @default.
- Q91037232 description "наукова стаття, опублікована 11 січня 2019" @default.
- Q91037232 name "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 name "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 type Item @default.
- Q91037232 label "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 label "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 prefLabel "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 prefLabel "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 P1104 Q91037232-CED78C16-0997-413C-82D5-1914F3991E59 @default.
- Q91037232 P1433 Q91037232-E68B29FD-37A1-447A-9CD1-9C164675256C @default.
- Q91037232 P1476 Q91037232-AB724080-BDC2-4A6D-94EB-02E762EBE7DB @default.
- Q91037232 P2093 Q91037232-0224E8F4-773E-4795-9E6D-B9C2FD0B8C46 @default.
- Q91037232 P2093 Q91037232-4DC02B0C-205D-4EF2-951C-169269785883 @default.
- Q91037232 P2093 Q91037232-65F3B2D4-7367-46DB-BEF8-30D3B25BC06E @default.
- Q91037232 P2093 Q91037232-667A72E6-B75E-4225-8C09-C2E7381C8BEF @default.
- Q91037232 P2093 Q91037232-9C3D9A17-0055-4644-B55C-C7A14345CAAB @default.
- Q91037232 P2093 Q91037232-B29D3027-8C21-4A33-9368-0228B27BDD46 @default.
- Q91037232 P2860 Q91037232-78E4B1EE-1C59-45BD-A542-2D27E179C93F @default.
- Q91037232 P2860 Q91037232-F8B98DE0-F813-4AE6-B3C5-48A00636FCB9 @default.
- Q91037232 P304 Q91037232-B0C4827A-9B4B-4F5D-B65B-938C2BB502E9 @default.
- Q91037232 P31 Q91037232-310A2BF2-4366-485B-8521-4144A430D9D4 @default.
- Q91037232 P356 Q91037232-CA494DC6-8BA7-47C3-A1DA-B54F8641755B @default.
- Q91037232 P478 Q91037232-F84D16D1-9A40-41A4-8D93-C1884C1441F3 @default.
- Q91037232 P577 Q91037232-FA91448E-14DF-4D26-87CD-69D269E73BF7 @default.
- Q91037232 P698 Q91037232-26A52384-465A-456E-913F-FF62998FFECD @default.
- Q91037232 P356 J.ABB.2019.01.012 @default.
- Q91037232 P698 30641047 @default.
- Q91037232 P1104 "+9" @default.
- Q91037232 P1433 Q635818 @default.
- Q91037232 P1476 "A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells" @default.
- Q91037232 P2093 "Atsushi Makiyama" @default.
- Q91037232 P2093 "Hitoshi Ashida" @default.
- Q91037232 P2093 "Songyan Jiang" @default.
- Q91037232 P2093 "Tomoya Kitakaze" @default.
- Q91037232 P2093 "Yoko Yamashita" @default.
- Q91037232 P2093 "Yumi Samukawa" @default.
- Q91037232 P2860 Q37315487 @default.
- Q91037232 P2860 Q44132992 @default.
- Q91037232 P304 "151-159" @default.
- Q91037232 P31 Q13442814 @default.
- Q91037232 P356 "10.1016/J.ABB.2019.01.012" @default.
- Q91037232 P478 "663" @default.
- Q91037232 P577 "2019-01-11T00:00:00Z" @default.
- Q91037232 P698 "30641047" @default.